PFKFB3, a key glucose metabolic enzyme regulated by pathogen recognition receptor TLR4 in liver cells.

Abstract

AIMS:

Toll-like receptor 4 (TLR4) and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB3) are involved in the progress of inflammation and glucose metabolism. Here, we aimed to assess the relationship between TLR4 and PFKFB3 in liver cells.

METHODS:

We detected the expression of TLR4 and PFKFB3 in both normal liver cell lines and liver cancer cell lines. Then, a small interfering RNA (siRNA) was used to knock down the expression of TLR4 and analyze the expression of PFKFB3 in the HL-7702 cell line. Further, following stimulation of the HL-7702 cell line with free fatty acids (FFA) or insulin, we observed the expression of TLR4 and PFKFB3, respectively.

RESULTS:

Knocking down siRNA-mediated TLR4 significantly reduced PFKFB3 expression at the mRNA and protein level. Furthermore, activating TLR4 with FFA dramatically increased PFKFB3 expression. Insulin increased the expression of TLR4 and PFKFB3, which could be inhibited by TLR siRNA.

CONCLUSION:

These findings suggest that PFKFB3 expression is regulated via the TLR4-PFKFB3 axis, which might be a bridge linking fat and glucose metabolism.

• Authors: Yan Lu, Lei Zhang, Ran Zhu, Huijuan Zhou, Huaying Fan, Qiang Wang
• Journal: Therapeutic advances in endocrinology and metabolism (Ther Adv Endocrinol Metab) Vol. 11 Pg. 2042018820923474 ( 2020) ISSN: 2042-0188 [Print] United States
• PMID: 32523673 (Publication Type: Journal Article, Retracted Publication)
• Copyright: © The Author(s), 2020.